ACCESS Newswire

    / PromiCell, Inc. (the “Company”), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell therapies for cancer patients, today announced that the Company’s Chief Medical Officer, John Lee, MD, Ph.D., will present interim results of the Company’s

    Latest News

    The Apple iPhone Duo redefines the book-style foldable category by adopting a practical “passport” aspect ratio (5.4-inch outer display, 7.6-inch inner display), a crease-mitigating nano-texture matte finish, and a vapor-cooled 2nm A20 Pro chip. It foregoes Face ID in favor